Information Journal Paper
APA:
Copy. (2017). First clinical results of ADCT‐ 402, a novel pyrrolobenzodiazepine-based antibody drug conjugate( ADC), in relapsed/refractory B‐ cell linage NHL. HEMATOLOGICAL ONCOLOGY, 35(S2), 49-51. SID. https://sid.ir/paper/752421/en
Vancouver:
Copy. First clinical results of ADCT‐ 402, a novel pyrrolobenzodiazepine-based antibody drug conjugate( ADC), in relapsed/refractory B‐ cell linage NHL. HEMATOLOGICAL ONCOLOGY[Internet]. 2017;35(S2):49-51. Available from: https://sid.ir/paper/752421/en
IEEE:
Copy, “First clinical results of ADCT‐ 402, a novel pyrrolobenzodiazepine-based antibody drug conjugate( ADC), in relapsed/refractory B‐ cell linage NHL,” HEMATOLOGICAL ONCOLOGY, vol. 35, no. S2, pp. 49–51, 2017, [Online]. Available: https://sid.ir/paper/752421/en